Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

HK$2.38As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1349Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (8.96%)
Div yield —
ROE (4.69%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.10
PE TTM —
TSR TTM (27.06%)
Mkt cap HK$6.684B
ROIC (12.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.55
7.13%
87.48%
Buy 10|11|3|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.03
12.38%
12.13%
14.74%
22.02%
Revenue¥M
410.8
405.2
394.4
383.6
0.30%
(5.99%)
(7.74%)
(8.92%)
Peers (US$852.6M)
Cap (US$)
PE
866.6M
46.93x
864.4M
29.67x
853.5M
8.360x
Capital
TTM
5Y
10Y
Leveragex
2.363
0.148
0.148
EBIT/Intx
3.069
1.007
0.854
Own earn%
(5.84)
(100.69)
(100.57)
Sh yield%
56.69
31.24
33.48
Owners
Insiders/Inst%
7.44
42.49
Short interest%
1.80
SBC / revenue%
5.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
26–33
$1 testx
−0.2
Incr. ROIC%
7